SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 2.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 35.6. According to RSI analysis, sunpharma is weak. 3.0 SUNPHARMA RSI Chart
MACD (?) MACD: -22.7 and Signal Line: -21.2. According to MACD analysis, sunpharma is technically weak. 2.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is in a strong downtrend. Major resistance levels are 501.04, 532.539, 621.095. 0.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is in a strong downtrend. Major resistance levels are 495.837, 528.8002, 616.4949. 0.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.285. 5.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 493.3616 and 512.1. Support level is 432.7. 2.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 17.1 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 39.5 which means SUNPHARMA is in a trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
August 23, 2017
Open Price 473.95
High Price 475.95
Low Price 467.6
Close Price 469.2
Absolute Change -1.25
Percentage Change -0.266%
Weekly Change -3.4%
Monthly Change -17.1%
Yearly Change -40.2%
52-week high 818.5
52-week low 432.7
Corporate Actions
ExDate Purpose
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
October 21, 2015 AGM/DIV-RS 3 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.599
Confidence in Beta1.85%
Market Capital Rs. 112922.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 52.7
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 August 2017: Deliverable Quantity:2.16e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 August 2017: Daily Volatility:0.4585 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 August 2017: PCR_OI:0.643 PCR:0.568 NA SUNPHARMA PCR Chart
Option Pain (?) 23 August 2017: Max Pain:480.0 NA SUNPHARMA Option Pain Chart
Premium (?) 23 August 2017 Premium: 1.05 Futures OI:34953600.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 23 August 2017: Price:469.2 Put with maximum OI:460.0 Call with maximum OI:500.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
August 31, 2017 470.25 34953600.0 5714.0 7168.0 469.2
September 28, 2017 469.5 5188000.0 2362.0 3167.0 469.2
October 26, 2017 471.9 152800.0 5.0 5.0 469.2

Announcements

August 16, 2017 SAmalgamation/MergerSun Pharmaceutical Industries Limited has informed the Exchange regarding "Approval of Scheme of Arrangement among Sun Pharma Medisales Private Limited, Ranbaxy Drugs Limited, Gufic Pharma Limited, Vidyut Investments Limited and the Company and their respective members and creditors".
August 14, 2017 SPress ReleaseSun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated August 11, 2017, titled "Sun Pharma reports Q1FY18 results".
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 26, 2017 August 11, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
January 27, 2017 February 14, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 457.5 Rs. 462.6 Rs. 465.9 Rs. 470.9 Rs. 474.2 Rs. 479.3 Rs. 482.6